Yao, Feiqun, and Zhewei Shi. 2023. “MiR-16 Is Promising to Be a Therapy Target to Alleviate Atherosclerosis”. Diagnostics and Therapeutics 2 (1):13-15. https://doi.org/10.55976/dt.22023116113-15.